Abicipar Pegol Phase 3 AMD Studies

Related

• 

  Preliminary Results from a First-in-human Phase I/II Gene Therapy Study (FOCUS) of Subretinally Delivered GT005, an Investigational AAV2 Vector, in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration

  Jared S. Nielsen, MD, MBA

  Updates from the Field

  2022

• 

  Episode 15: Serum VEGF Levels in the IVAN Trial with Dr. Usha Chakravarthy

  Keyvan Koushan, MD, FRCSC

  Member Podcasts

  2018

• 

  Chronical Submacular Hemorrhage in the Setting of Neovascular AMD

  Rita Couceiro, MD, MS

  carlos marques-neves, MD, PhD, EBO

  Retina Image Bank: Images of the Week

  2015